JP2014513983A5 - - Google Patents

Download PDF

Info

Publication number
JP2014513983A5
JP2014513983A5 JP2014510518A JP2014510518A JP2014513983A5 JP 2014513983 A5 JP2014513983 A5 JP 2014513983A5 JP 2014510518 A JP2014510518 A JP 2014510518A JP 2014510518 A JP2014510518 A JP 2014510518A JP 2014513983 A5 JP2014513983 A5 JP 2014513983A5
Authority
JP
Japan
Prior art keywords
cells
zscan4
seq
reprogramming
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014510518A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014513983A (ja
JP6189829B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/037643 external-priority patent/WO2012158561A1/en
Publication of JP2014513983A publication Critical patent/JP2014513983A/ja
Publication of JP2014513983A5 publication Critical patent/JP2014513983A5/ja
Application granted granted Critical
Publication of JP6189829B2 publication Critical patent/JP6189829B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014510518A 2011-05-13 2012-05-11 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化 Active JP6189829B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161486004P 2011-05-13 2011-05-13
US61/486,004 2011-05-13
US201161529055P 2011-08-30 2011-08-30
US61/529,055 2011-08-30
PCT/US2012/037643 WO2012158561A1 (en) 2011-05-13 2012-05-11 Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017108578A Division JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Publications (3)

Publication Number Publication Date
JP2014513983A JP2014513983A (ja) 2014-06-19
JP2014513983A5 true JP2014513983A5 (https=) 2015-07-16
JP6189829B2 JP6189829B2 (ja) 2017-08-30

Family

ID=47177285

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014510518A Active JP6189829B2 (ja) 2011-05-13 2012-05-11 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化
JP2017108578A Pending JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017108578A Pending JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Country Status (6)

Country Link
US (1) US9932560B2 (https=)
EP (1) EP2707479B1 (https=)
JP (2) JP6189829B2 (https=)
AU (1) AU2012256014B2 (https=)
CA (1) CA2835825C (https=)
WO (1) WO2012158561A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2835825C (en) 2011-05-13 2021-03-23 Minoru S.H. Ko Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells
CN105246490A (zh) 2013-03-15 2016-01-13 伊利克斯根公司 使用zscan4复壮人细胞的方法
WO2016099602A1 (en) * 2014-12-18 2016-06-23 University Of Utah Research Foundation Induced pluripotent stem cell and method for producing the same
CN105219729B (zh) * 2015-09-28 2018-09-25 首都医科大学宣武医院 一种利用非整合质粒载体诱导神经干细胞的方法及其用途
CN106800590B (zh) * 2015-11-25 2021-04-09 杭州智鹤丹谷生物医药有限公司 一种结合多种淀粉样蛋白单体和聚集体的多肽及其应用
US20200087723A1 (en) * 2016-12-15 2020-03-19 Illumina, Inc. Methods and systems for determining paralogs
CN107475378B (zh) * 2017-08-03 2021-03-30 复旦大学 用于检测女性原发不孕的patl2基因及检测该基因突变的试剂盒
WO2019060450A1 (en) * 2017-09-19 2019-03-28 The Broad Institute, Inc. METHODS AND SYSTEMS FOR RECONSTRUCTION OF DEVELOPMENT LANDSCAPES BY OPTIMAL TRANSPORT ANALYSIS
CN107988147B (zh) * 2017-12-19 2021-11-09 江汉大学 基于器官芯片与诱导多能干细胞的定向分化用于3d拟表皮构建的方法
WO2020237209A1 (en) * 2019-05-22 2020-11-26 University Of Maryland, Baltimore Methods of treating cancer by targeting zscan4 activity in cancer stem cells
CN110616232B (zh) * 2019-09-23 2023-04-11 中国人民解放军陆军军医大学 Sox30敲除和可恢复型小鼠动物模型构建方法及应用
JP7699588B2 (ja) * 2019-11-22 2025-06-27 アルカメナ・ステム・セル・セラピューティクス、エルエルシー Re1サイレンシング転写因子標的遺伝子を抑制解除する組成物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
KR100201352B1 (ko) 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US7198784B2 (en) 1996-10-17 2007-04-03 Oxford Biomedica (Uk) Limited Retroviral vectors
FR2762615B1 (fr) 1997-04-28 1999-07-16 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes et vecteur le contenant
WO2000078987A1 (en) 1999-06-22 2000-12-28 Dnavec Research Inc. Vector for expressing two foreign genes
US20110171185A1 (en) * 1999-06-30 2011-07-14 Klimanskaya Irina V Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
DE19933492B4 (de) 1999-07-16 2008-01-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung
CA2392490A1 (en) 1999-11-24 2001-05-31 Mcs Micro Carrier Systems Gmbh Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
US7211247B2 (en) 2001-04-09 2007-05-01 University Of Southern California Lentivirus vectors for gene transfer to alveolar epithelial cells
US7081489B2 (en) 2001-08-09 2006-07-25 Florida State University Research Foundation Polymeric encapsulation of nanoparticles
US20040014209A1 (en) 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
US7354763B2 (en) 2002-04-16 2008-04-08 Technion Research & Development Foundation Ltd. Generating vascular smooth muscle cells in vitro from ES cells
AU2003257181A1 (en) 2002-08-05 2004-02-23 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
KR100591936B1 (ko) 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 dna/rna 전달 방법, 및 이것의 기초 및임상학적 응용
EP1583473A2 (en) 2003-01-16 2005-10-12 St. Johns University New York Nanoparticle based stabilization of ir fluorescent dyes
US7166692B2 (en) 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
BRPI0507074A (pt) 2004-01-23 2007-06-19 Advanced Cell Tech Inc modalidades aperfeiçoadas para o tratamento de doenças degenerativas da retina
WO2006052285A2 (en) 2004-05-13 2006-05-18 The Trustees Of Columbia University In The City Of New York Polymeric nanoparticles and nanogels for extraction and release of compounds
US20060024331A1 (en) 2004-08-02 2006-02-02 Ester Fernandez-Salas Toxin compounds with enhanced membrane translocation characteristics
JP2008528038A (ja) 2005-01-31 2008-07-31 エス セル インターナショナル ピーティーイー リミテッド 胚性幹細胞の指示された分化及びその利用
ATE382337T1 (de) 2005-04-28 2008-01-15 Nipro Corp Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
CA2605551A1 (en) 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering rnaiii-inhibiting peptides
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
CA2678901C (en) * 2007-03-26 2017-11-14 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for modulating embryonic stem cell differentiation
SG10201400329YA (en) 2008-05-02 2014-05-29 Univ Kyoto Method of nuclear reprogramming
AU2010289423B2 (en) * 2009-09-04 2014-03-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for enhancing genome stability and telomere elongation in embryonic stem cells
AU2012230894B2 (en) 2011-03-23 2017-01-05 Elixirgen, Llc Compositions and methods for enhancing the pluripotency of stem cells
CA2835825C (en) 2011-05-13 2021-03-23 Minoru S.H. Ko Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells

Similar Documents

Publication Publication Date Title
JP2014513983A5 (https=)
JP7022878B2 (ja) 細胞リプログラミング
Ratajczak et al. A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells
Roubelakis et al. Amniotic fluid and amniotic membrane stem cells: marker discovery
Lee et al. iPSC-derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs
KR101686722B1 (ko) 신경줄기세포 제조를 위한 배지와 그의 용도
US9764063B2 (en) Method for producing mixed cell population of cardiomyocytes and vascular cells from induced pluripotent stem cell
CN102844428B (zh) Ets2和mesp1由成纤维细胞生成心脏祖细胞
Abu Kasim et al. Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources
US20150232810A1 (en) Methods of preparing pluripotent stem cells
Kruminis-Kaszkiel et al. Differentiation of human mesenchymal stem cells from Wharton’s Jelly towards neural stem cells using a feasible and repeatable protocol
JP6373253B2 (ja) 新規心筋細胞マーカー
US20140093481A1 (en) Production of dentin, cementum and enamel by cells
JP6025067B2 (ja) 新規心筋細胞マーカー
JP2011068660A5 (https=)
AU2018286654A1 (en) Cell reprogramming to cardiomyocytes
Zhao et al. Heparan Sulfate Chain‐Conjugated Laminin‐E8 Fragments Advance Paraxial Mesodermal Differentiation Followed by High Myogenic Induction from hiPSCs
JP2012532592A5 (https=)
Sun et al. MiR-98-5p regulates myocardial differentiation of mesenchymal stem cells by targeting TBX5.
CN102628029B (zh) 地贫诱导多能干细胞及其制备方法和用途
JPWO2016114341A1 (ja) 多能性細胞識別化合物
KR20230113768A (ko) 유도 줄기 세포
CN104450622A (zh) 一种重组细胞系、其制备方法和应用
Paulitschek et al. Generation and characterization of two iPSC lines from human epicardium-derived cells
CN115175986B (zh) 用于诱导多能干细胞向脑毛细血管内皮样细胞分化的涂布剂及其利用